Quality ManagementMedicare AdvantageMarch 31, 2025

Kidney Health Evaluation for Patients With Diabetes (KED) 2025

HEDIS® is a widely used set of performance measures developed and maintained by NCQA. These are used to drive improvement efforts surrounding best practices.

HEDIS measure

This measure evaluates patients 18 to 85 years of age with diabetes (type 1 and type 2) who received a kidney health evaluation, defined by an estimated glomerular filtration rate (eGFR), and a urine albumin-creatinine ratio (uACR) during the measurement year.

Refer to attachments to view full details

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Medicare services provided by Anthem Blue Cross and Blue Shield, trade name of Anthem HealthChoice HMO, Inc. and Anthem HealthChoice Assurance, Inc., Anthem Blue Cross and Blue Shield HP, trade name of Anthem HP, LLC., or Anthem Blue Cross and Blue Shield Retiree Solutions, trade name of Anthem Insurance Companies, Inc.
Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-075750-24-CPN74992, MULTI-BC-CR-075749-24-CPN74992, MULTI-BC-CR-080033-25 CPN79905, MULTI-BCBS-CR-080034-25 CPN79905

ATTACHMENTS: Kidney Health Evaluation for Patients With Diabetes (KED) 2025 - Blue Cross (pdf - 0mb), Kidney Health Evaluation for Patients With Diabetes (KED) 2025 - Blue Cross Blue Shield (pdf - 0mb)